Predicted ETS binding sites 2 and 3 within the muscle heart enhancer (MHE) of the endogenous eve locus have been mutated. In addition, a FspI restriction site has been introduced upstream of the MHE and a BamHI restriction site has been introduced downstream of the MHE.